Skip to main content
Erschienen in: Clinical & Experimental Metastasis 5/2017

07.06.2017 | Commentary

PIPAC puts pressure on peritoneal metastases from pancreatic cancer

verfasst von: Jonathan P. Sleeman

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Excerpt

The seeding of metastases into the peritoneal cavity is a feature of a number of gynecological and gastrointestinal cancers, and is termed peritoneal carcinomatosis when metastasis is extensive [1]. The incidence varies according to the cancer type (Table 1). The development of ascites is a further complication associated with peritoneal metastasis. …
Literatur
7.
Zurück zum Zitat Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hubner M (2017) Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg 104:669–678. doi:10.1002/bjs.10521 CrossRefPubMed Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hubner M (2017) Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg 104:669–678. doi:10.​1002/​bjs.​10521 CrossRefPubMed
8.
Zurück zum Zitat Girshally R, Demtroder C, Albayrak N, Zieren J, Tempfer C, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 14:253. doi:10.1186/s12957-016-1008-0 CrossRefPubMedPubMedCentral Girshally R, Demtroder C, Albayrak N, Zieren J, Tempfer C, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 14:253. doi:10.​1186/​s12957-016-1008-0 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Tempfer CB, Winnekendonk G, Solass W, Horvat R, Giger-Pabst U, Zieren J, Rezniczek GA, Reymond MA (2015) Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol 137:223–228. doi:10.1016/j.ygyno.2015.02.009 CrossRefPubMed Tempfer CB, Winnekendonk G, Solass W, Horvat R, Giger-Pabst U, Zieren J, Rezniczek GA, Reymond MA (2015) Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol 137:223–228. doi:10.​1016/​j.​ygyno.​2015.​02.​009 CrossRefPubMed
11.
Zurück zum Zitat Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB (2017) Peritoneal carcinomatosis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis. doi:10.1007/s10585-017-9849-7 PubMed Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB (2017) Peritoneal carcinomatosis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis. doi:10.​1007/​s10585-017-9849-7 PubMed
12.
Zurück zum Zitat Kakchekeeva T, Demtroder C, Herath NI, Griffiths D, Torkington J, Solass W, Dutreix M, Reymond MA (2016) In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol 23:592–598. doi:10.1245/s10434-016-5108-4 CrossRefPubMedPubMedCentral Kakchekeeva T, Demtroder C, Herath NI, Griffiths D, Torkington J, Solass W, Dutreix M, Reymond MA (2016) In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol 23:592–598. doi:10.​1245/​s10434-016-5108-4 CrossRefPubMedPubMedCentral
Metadaten
Titel
PIPAC puts pressure on peritoneal metastases from pancreatic cancer
verfasst von
Jonathan P. Sleeman
Publikationsdatum
07.06.2017
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 5/2017
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-017-9851-0

Weitere Artikel der Ausgabe 5/2017

Clinical & Experimental Metastasis 5/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.